anthem glp-1 coverage 2025 Paving the way for expanded | Insights & Events Weight Management - Gennev: Expert

Lopez PD, Bhatia K, Bohra C, et al

Case series 1: Under medical oversight, two individuals with Bardet-Biedl syndrome and type 2 diabetes mellitus lost 15% of their total body weight in a 3- and 5-month period, respectively, following a combination therapy of tirzepatide and setmelanotide

2010b;285:2450824518

GLP-1 receptor agonists promote weight loss and improve metabolic health

While incredibly effective for weight loss and blood sugar control, these medications significantly alter eating patterns and digestion

Unlimited provider visits Shed Community access with resources, educational courses, nutrition plans, and continuous support Support from our Member Success and medical teams every step of the way Complimentary text-based Health Coaching** for ongoing guidance Dedicated support on prescription ordersno more insurance hassles